|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
SCIDIR_ocn976434023 |
003 |
OCoLC |
005 |
20231120112219.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
170320s2017 ne o 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d N$T
|d IDEBK
|d YDX
|d OCLCF
|d UPM
|d OTZ
|d OCLCQ
|d D6H
|d MMU
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 979241754
|a 979910435
|
020 |
|
|
|a 9780444639431
|q (electronic bk.)
|
020 |
|
|
|a 0444639438
|q (electronic bk.)
|
020 |
|
|
|z 9780444639394
|q (print)
|
020 |
|
|
|z 044463939X
|q (print)
|
035 |
|
|
|a (OCoLC)976434023
|z (OCoLC)979241754
|z (OCoLC)979910435
|
050 |
|
4 |
|a RS403
|
060 |
|
4 |
|a QV 744
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
245 |
0 |
0 |
|a Progress in medicinal chemistry.
|n Volume 56 /
|c edited by David R. Witty and Brian Cox.
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c 2017.
|
300 |
|
|
|a 1 online resource (x, 185 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
505 |
0 |
|
|a Enabling chemistry technologies and parallel synthesis: accelerators of drug discovery programmes -- Development of LRRK2 inhibitors for the treatment of Parkinson's disease -- Recent progress in the discovery and development of TRPA1 modulators -- Small molecule inhibition of interleukin-1 receptor-associated kinase 4 (IRAK4).
|
520 |
|
|
|a "Progress in Medicinal Chemistry, Volume 56 provides a review of eclectic developments in medicinal chemistry. This volume includes chapters covering recent advances in cancer therapeutics, fluorine in medicinal chemistry, a perspective on the next generation of antibacterial agents derived by manipulation of natural products, a potential new era for Chagas Disease drug discovery, and imaging in drug development. Specific chapters cover timely topics, such as the development of LRRK2 inhibitors for the treatment of Parkinson's, and recent discoveries and developments in TRPA1 modulators. Users will find a comprehensive resource on the topic of medicinal chemistry that also discusses avenues for the acceleration of drug discovery programs"--Publisher's description.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed March 22, 2017).
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
1 |
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
7 |
|a MEDICAL / Pharmacology
|2 bisacsh
|
650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
700 |
1 |
|
|a Witty, D. R.
|q (David R.),
|e editor.
|
700 |
1 |
|
|a Cox, Brian
|c (Chemist),
|e editor.
|
776 |
0 |
8 |
|i Online version:
|a Witty, David R.
|t Progress in medicinal chemistry.
|d Amsterdam, Netherlands : Elsevier, 2017.
|z 044463939X
|w (OCoLC)964377730
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/00796468/56
|z Texto completo
|